House Democrats launch probe into MS drug pricing

NEW YORK (Reuters) - Democrats on the House Committee on Oversight and Government Reform said on Thursday they are launching an investigation into price increases for Multiple Sclerosis (MS) drugs and sent letters requesting information from seven drugmakers.